//
Genotype-Guided Strategy for Oral P2Y12 Inhibitors
Management of two major complications in the cardiac catheterisation laboratory: the no-reflow phenomenon and coronary perforations
Translational Perspective on Epigenetics in Cardiovascular Disease
Screening for Atrial Fibrillation With Electrocardiography US Preventive Services Task Force Recommendation Statement
Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Metallic Stents
Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association
High-Risk Coronary Atherosclerosis Is It the Plaque Burden, the Calcium, the Lipid, or Something Else?
A sirolimus-eluting bioabsorbable polymer-coated stent (MiStent) versus an everolimus-eluting durable polymer stent (Xience) after percutaneous coronary intervention (DESSOLVE III): a randomised, single-blind, multicentre, non-inferiority, phase 3 trial